Ticker Details
Array Technologies, Inc. Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
IPO Date:	October 15, 2020
Sector:	Technology
Industry:	Solar
Market Cap:	$1.1B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.50 | 3.32%
Avg Daily Range (30 D):	$0.24 | 3.36%
Avg Daily Range (90 D):	$0.31 | 3.45%

Institutional Daily Volume
Avg Daily Volume:	4.5M
Avg Daily Volume (30 D):	5.48M
Avg Daily Volume (90 D):	5.05M

Trade Size
Avg Trade Size (Sh.):	123
Avg Trade Size (Sh.) (30 D):	127
Avg Trade Size (Sh.) (90 D):	123

Institutional Trades
Total Institutional Trades:	6,386
Avg Institutional Trade:	$2.31M
Avg Institutional Trade (30 D):	$2.36M
Avg Institutional Trade (90 D):	$2.74M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$5.02M
Avg Closing Trade (30 D):	$4.64M
Avg Closing Trade (90 D):	$4.71M
Avg Closing Volume:	378.16K

News

Feb 10, 2026 @ 3:00 PM Array Acquires Chimney to Expand Digital Financial... Source: Not Specified

Jan 20, 2026 @ 10:10 PM 3 Bold Predictions to Start 2026 Source: Motley Fool Staff

Jan 13, 2026 @ 7:02 PM Where Will Nextpower (NXT) Stock Be in 1 Year? Source: Leo Sun

Sep 28, 2025 @ 11:30 AM Is Nextracker Stock a Buy Now? Source: Leo Sun

Aug 21, 2025 @ 12:00 PM Shoals Technologies Group Appoints Aaron Zadeh as ... Source: Shoals Technologies Group

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.73	$-1.05	$-.73
Diluted EPS	$-.73	$-1.05	$-.73
Revenue	$1.28B	$226.04M	$1.28B
Gross Profit	$298.55M	$19.33M	$298.55M
Net Income / Loss	$-52.24M	$-145.75M	$-52.24M
Operating Income / Loss	$-29M	$-148.11M	$-29M
Cost of Revenue	$985.59M	$206.71M	$985.59M
Net Cash Flow	$-118.16M	$22.88M	$-118.16M
PE Ratio